Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Por van den Bent, Martin J., Brandes, Alba A., Rampling, Roy, Kouwenhoven, Mathilde C.M., Kros, Johan M., Carpentier, Antoine F., Clement, Paul M., Frenay, Marc, Campone, Mario, Baurain, Jean-Francois, Armand, Jean-Paul, Taphoorn, Martin J.B., Tosoni, Alicia, Kletzl, Heidemarie, Klughammer, Barbara, Lacombe, Denis, Gorlia, Thierry
Publicado em 2009